Loading...
XSHE300244
Market cap848mUSD
Jan 13, Last price  
10.38CNY
1D
0.00%
1Q
-17.68%
Jan 2017
-67.56%
IPO
152.54%
Name

Dian Diagnostics Group Co Ltd

Chart & Performance

D1W1MN
XSHE:300244 chart
P/E
20.23
P/S
0.46
EPS
0.51
Div Yield, %
4.83%
Shrs. gr., 5y
2.70%
Rev. gr., 5y
13.99%
Revenues
13.41b
-33.89%
178,290,078263,253,242343,273,048482,474,271706,418,7231,015,474,4361,335,100,1441,858,180,8893,823,980,6235,004,124,1786,966,857,3668,453,207,04710,649,161,77213,082,613,20020,282,469,25813,408,319,799
Net income
307m
-78.56%
6,589,69117,168,78732,411,25642,208,33160,187,69386,093,289124,584,445174,794,712262,760,903349,592,987388,608,434575,568,057802,932,5431,162,884,3461,434,191,144307,461,061
CFO
1.92b
+17.20%
04,056,35441,225,46220,204,16825,656,07375,438,947117,949,327131,286,595132,247,09438,510,798373,237,375483,185,6271,547,226,9921,317,918,1471,639,364,9921,921,354,006
Dividend
Sep 20, 20240.65 CNY/sh
Earnings
May 20, 2025

Profile

Dian Diagnostics Group Co.,Ltd. operates as a third-party independent medical diagnostic service company in China. It offers medical diagnosis solutions for various general hospitals and specialty hospitals, community health service centers, township health centers, physical examination centers, disease prevention and control centers, and other medical and health institutions. The company operates 40 chain laboratories worldwide. It also engages in the research, development, and production of in vitro diagnostic reagents and related equipment and consumables; provision of medical equipment, drugs, clinical samples, biological products, virus and microorganisms, finished blood, live animals, compounds, and diagnostic reagents, as well as other cold chain transportation, warehousing services, cold chain product sales, and technical services. The company was formerly known as Zhejiang DIAN Diagnostics Co., Ltd. and changed its name to Dian Diagnostics Group Co.,Ltd. in November 2017. Dian Diagnostics Group Co.,Ltd. was founded in 2001 and is based in Hangzhou, China.
URL
https://www.dazd.cn/
IPO date
Jul 19, 2011
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
13,408,320
-33.89%
20,282,469
55.03%
Cost of revenue
10,443,528
15,252,253
Unusual Expense (Income)
NOPBT
2,964,792
5,030,216
NOPBT Margin
22.11%
24.80%
Operating Taxes
216,735
681,092
Tax Rate
7.31%
13.54%
NOPAT
2,748,057
4,349,124
Net income
307,461
-78.56%
1,434,191
23.33%
Dividends
(300,623)
(83,762)
Dividend yield
2.02%
0.53%
Proceeds from repurchase of equity
(40,962)
(1)
BB yield
0.28%
0.00%
Debt
Debt current
930,565
2,733,230
Long-term debt
2,909,056
3,601,574
Deferred revenue
10,333
25,287
Other long-term liabilities
498,525
490,131
Net debt
(222,421)
1,050,705
Cash flow
Cash from operating activities
1,921,354
1,639,365
CAPEX
(701,774)
Cash from investing activities
(625,669)
Cash from financing activities
(2,504,878)
1,428,181
FCF
3,183,012
1,973,066
Balance
Cash
3,391,636
4,650,126
Long term investments
670,406
633,974
Excess cash
3,391,626
4,269,976
Stockholders' equity
7,809,171
7,737,082
Invested Capital
10,572,188
11,401,215
ROIC
25.01%
42.18%
ROCE
21.23%
32.09%
EV
Common stock shares outstanding
625,175
624,023
Price
23.81
-5.25%
25.13
-25.14%
Market cap
14,885,417
-5.08%
15,681,687
-24.71%
EV
17,001,510
18,786,291
EBITDA
3,656,232
5,829,716
EV/EBITDA
4.65
3.22
Interest
250,602
274,728
Interest/NOPBT
8.45%
5.46%